United States · FDA National Drug Code directory
Verapamil Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 25021-312_b4eb5dd2-5e25-4ecc-ac57-8897f2b6984a
- Product NDC
- 25021-312
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Verapamil Hydrochloride
- Labeler
- Sagent Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210315
- Source listing expiry
- 20261231
Source-listed ingredients
- VERAPAMIL HYDROCHLORIDE — 2.5 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (25021-312-02) / 2 mL in 1 VIAL · 25021-312-02
- 5 VIAL in 1 CARTON (25021-312-04) / 4 mL in 1 VIAL · 25021-312-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →